The European ｕｎｉｏｎ: EC 1223/2009 and the Cosmetic Product Safety Report

The European ｕｎｉｏｎ maintains one of the most stringent regulatory frameworks for cosmetic products through Regulation (EC) No. 1223/2009. Under this regulation, every cosmetic product placed on the EU market must have a designated Responsible Person — typically the manufacturer, importer, or distributor established within the EU — who ensures compliance with all applicable requirements.

A central requirement is the Cosmetic Product Safety Report (CPSR), which must be prepared by a qualified safety assessor. For botanical extracts, the CPSR must address several specific considerations:

• Complete toxicological profile of each botanical ingredient, including data on the plant part used, extraction solvent, and concentration of active compounds
• Assessment of potential contaminants including heavy metals, pesticides, and microbial limits
• Evaluation of phototoxicity potential for leave-on products
• Dermal irritation and sensitization data
• Stability and compatibility testing within the finished formulation

The EU also requires a Product Information File (PIF) containing the CPSR, a description of the manufacturing method, proof of claimed effects, and data on any animal testing — which has been banned for cosmetic ingredients in the EU since 2009. Brands sourcing botanical ingredients must ensure that their supply chain documentation fully supports PIF requirements.

United States: FDA Oversight and MoCRA Requirements

In the United States, cosmetic products are regulated by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act. Unlike the EU, the US does not require pre-market approval for cosmetic products or ingredients — with the exception of color additives. However, the Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022, significantly expanded the FDA's regulatory authority.

Key MoCRA requirements affecting botanical skincare products include:

• Mandatory facility registration and product listing with the FDA, renewed biennially
• Adverse event reporting requirements, including serious adverse event reporting within 15 business days
• Safety substantiation records demonstrating that the product is safe under labeled conditions of use
• Good Manufacturing Practice (GMP) compliance aligned with the FDA's cosmetic GMP guidelines
• Mandatory labeling of fragrance allergens once the FDA finalizes its list

For botanical extracts specifically, the FDA expects manufacturers to ensure that raw materials are properly identified, tested for contaminants, and supported by adequate safety data. While the FDA does not mandate specific tests, the industry standard involves heavy metal analysis, pesticide residue screening, and microbial limits testing.

China: NMPA Cosmetics Supervision and Administration Regulation

China has emerged as one of the most important markets for botanical skincare products, and its regulatory framework has undergone significant modernization. The Cosmetics Supervision and Administration Regulation (CSAR), implemented in 2021, introduced a risk-based classification system that distinguishes between general cosmetics and special cosmetics (such as sunscreens, hair dyes, and whitening products).

For botanical extract-based skincare products entering the Chinese market, several requirements are critical:

• General cosmetics must be filed with the NMPA, while special cosmetics require formal registration and approval
• A domestic responsible agent must be appointed for imported products
• Product safety assessment must follow the NMPA's Technical Guidelines for Cosmetic Safety Assessment
• Botanical ingredients must comply with the Inventory of Existing Cosmetic Ingredients in China (IECIC)
• Efficacy claims must be substantiated through testing conducted in accordance with NMPA-recognized methods

Notably, China maintains a limited acceptance of animal testing alternatives for general cosmetics produced in facilities that meet GMP standards and have established safety records. However, for special cosmetics and certain imported products, animal testing may still be required, making it essential for brands to work with manufacturers who understand the nuances of Chinese regulatory pathways.

Essential Safety Assessments for Botanical Extracts

Regardless of the target market, botanical extracts used in skincare products must undergo a core set of safety assessments. These evaluations serve as the foundation for regulatory submissions and provide assurance that the ingredient is safe for its intended use.

Heavy Metal Analysis

Botanical raw materials can accumulate heavy metals from soil, water, and processing environments. Standard testing includes lead, arsenic, mercury, and cadmium, with limits typically aligned to ICH Q3D guidelines or regional pharmacopoeia standards. Reputable manufacturers provide certificates of analysis (CoA) for every batch.

Pesticide Residue Screening

Plant materials may carry pesticide residues from agricultural cultivation. Testing should cover a broad panel of pesticides following multi-residue methods such as those outlined in the European Pharmacopoeia or USP. The EU sets specific maximum residue limits (MRLs) that must be observed for products sold in the European market.

Microbial Limits Testing

Botanical extracts must meet microbial quality standards to ensure product safety throughout shelf life. Standard testing includes total aerobic microbial count, total yeast and mold count, and absence of specified pathogens including Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. These limits are generally defined by ISO 17516 or equivalent regional standards.

Solvent Residue Analysis

When botanical extracts are produced using solvent-based extraction methods, residual solvent levels must be quantified and controlled. The ICH Q3C guideline classifies solvents by toxicity and establishes permitted daily exposure limits. Manufacturers should document the extraction solvents used and provide residual solvent data.

Quality Standards and Documentation

Beyond safety testing, regulatory compliance depends on comprehensive documentation throughout the supply chain. Brands should expect the following documentation from their botanical extract suppliers:

• Certificate of Analysis (CoA): Batch-specific documentation confirming identity, purity, potency, and compliance with specifications
• Specification Sheet: Detailed product specifications including botanical source, extraction method, standardization markers, and acceptance criteria
• Material Safety Data Sheet (MSDS/SDS): Safety information covering handling, storage, and emergency procedures
• GMP Certificates: Evidence of manufacturing under Good Manufacturing Practice conditions
• Stability Data: Results from accelerated and real-time stability studies supporting the assigned shelf life
• Allergen Statement: Documentation of known allergens present in the botanical material

For organic claims, additional certification from recognized bodies such as USDA NOP or EU Organic is required, along with full traceability documentation from farm to finished extract.

Navigating Regional Differences

One of the greatest challenges for skincare brands is managing the divergent requirements across different regulatory jurisdictions. A product compliant in the EU may require additional documentation or testing for the US or Chinese markets. Key areas of divergence include:

• Permitted ingredients: The EU maintains a negative list of prohibited substances and a positive list of permitted preservatives, colorants, and UV filters. The US and China maintain their own distinct lists.
• Animal testing: The EU and several other markets have banned animal testing for cosmetics. China has moved toward accepting alternatives for general cosmetics but retains testing requirements for certain categories.
• Labeling requirements: INCI nomenclature is widely used internationally, but additional labeling requirements — such as language, allergen disclosure, and quantitative ingredient declarations — vary by market.
• Efficacy claims: The level of substantiation required for marketing claims differs significantly. The EU requires evidence in the PIF, while China requires pre-market efficacy testing for specific claim categories.

The Role of Quality-Focused Botanical Extract Manufacturers

Working with an experienced and compliance-focused botanical extract manufacturer is one of the most effective ways to manage regulatory complexity. A manufacturer with robust quality systems and regulatory expertise can provide the documentation, testing data, and technical support needed to streamline the compliance process.

Botaniex, as a botanical extract manufacturer based in Changsha, China, maintains rigorous quality control protocols that include raw material authentication, in-process monitoring, active compound verification, and comprehensive microbial testing. The company's R&D team — comprising PhDs, professors, and researchers in phytochemistry and pharmacology — supports clients with technical documentation including specification sheets, certificates of analysis, stability data, and safety documentation aligned with international regulatory standards.

For brands developing botanical skincare products, the key considerations when selecting a supplier include: availability of complete regulatory documentation packages, demonstrated understanding of target market requirements, batch-to-batch consistency supported by standardization processes, and transparent communication about extraction methods and quality parameters.

Practical Steps for Compliance

To summarize, brands developing botanical extract skincare products should follow these practical steps to ensure regulatory compliance:

1. Identify all target markets early in the development process and map out the specific regulatory requirements for each jurisdiction.
2. ｓｅｌｅｃｔ botanical extract suppliers who can provide comprehensive regulatory documentation, including CoAs, specifications, safety data, and stability reports.
3. Engage a qualified safety assessor to prepare the required safety assessments, ensuring that botanical-specific considerations — such as plant part, extraction solvent, and natural variability — are addressed.
4. Conduct stability and compatibility testing on the finished formulation to confirm that botanical ingredients remain stable throughout the product's shelf life.
5. Prepare and maintain a complete Product Information File or equivalent documentation package for each product.
6. Stay informed about regulatory updates, as multiple jurisdictions are actively revising their cosmetics regulations, particularly concerning botanical and natural ingredients.